Clinical Trials Directory

Trials / Unknown

UnknownNCT00673140

Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)

Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig's Disease

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
7 (actual)
Sponsor
GAAD Medical Research Institute Inc. · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Amyotrophic Lateral Sclerosis (ALS, sometimes called Lou Gehrig's s Disease, or Maladie de Charcot) is a progressive, usually fatal, neurodegenerative disease caused by the degeneration of motor neurons, the nerve cells in the central nervous system that control voluntary muscle movement. This study will investigate the use of far infrared radiation for the control, management and treatment of ALS.

Detailed description

As a motor neuron disease, ALS causes muscle weakness and atrophy throughout the body as both the upper and lower motor neurons degenerate, ceasing to send messages to muscles. Unable to function, the muscles gradually weaken, develop fasciculations (twitches) because of denervation, and eventually atrophy due to that denervation. The patient may ultimately lose the ability to initiate and control all voluntary movement except of the eyes. Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells. It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have ALS.

Conditions

Interventions

TypeNameDescription
RADIATIONFar Infrared Radiation (5μm to 20μm wavelength)Radiation: Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.
RADIATIONFar infrared radiationFar infrared radiation at a frequency of 5 microns to 20 microns for 30 to 40 minutes per session.

Timeline

Start date
2008-05-01
Primary completion
2010-05-01
Completion
2010-06-01
First posted
2008-05-07
Last updated
2009-08-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00673140. Inclusion in this directory is not an endorsement.